Last reviewed · How we verify
NCT05341895
Kinesiotape on Balance in With Multiple Sclerosis
NA trial testing Kinesiotape in Individuals With Multiple Sclerosis in 60 participants. Status unknown.
22 April 2022
Quick facts
| Lead sponsor | Firat University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 22 November 2021 |
| Primary completion | 22 April 2022 |
| Estimated completion | 6 May 2022 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Kinesiotape
Conditions studied
- Individuals With Multiple Sclerosis — all drugs for Individuals With Multiple Sclerosis →
- With Ataxia Symptoms — all drugs for With Ataxia Symptoms →
- No Secondary Disease Affecting Balance — all drugs for No Secondary Disease Affecting Balance →
Sponsor
Firat University
Who can join
Adults 18 to 65, any sex, with Individuals With Multiple Sclerosis or With Ataxia Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multiple Sclerosis (MS), a chronic inflammatory disease of the central nervous system, is a disease characterized by myelin, oligodendrocyte and axon damage. Research continues on the autoimmune, infectious, environmental, vascular and genetic origins of this disease, which affects approximately 2.5 million people in the world and is seen 2-3 times more in women than in men. Although the signs and symptoms of the disease vary according to the location of the lesion; frequently, loss of strength, spasticity, sensory disturbances, fatigue, ataxia, autonomic dysfunction, and decreased visual acuity are observed. With these approaches, the effect of Kinesiotape application on balance will be investigated in individuals with ataxic MS. Based on this idea, our work; It was planned to investigate the effect of kinesiotape application on balance in individuals diagnosed with ataxic multiple sclerosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05341895
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Kinesiotape
Trials testing the same drug.
- NCT07358936 — THE EFFECTS OF CORRECTIVE EXERCISE AND KT APPLICATIONS IN YOUNG BASKETBALL PLAYERS · NA · recruiting
- NCT06640543 — Effect of Kinesiotape Versus Myofascial Release on Postnatal Low Back Pain · NA · completed
- NCT06302920 — Effect of Kinesiotaping on Pain,Edema and Kinesiophobia in Patients With Complex Regional Pain Syndrome · NA · unknown
- NCT06407492 — Complementary Medicine Practices in Chronic Low Back Pain: Randomized Controlled Trial · NA · completed
- NCT06709105 — The Effect of Kinesiotaping in Pregnant Women · NA · completed
Other Firat University trials
Trials by the same sponsor.
- NCT07520799 — The Effect of Mindfulness-Based Breathing Exercises on Dyspnea, Symptom Control, and Quality of Life in Lung Cancer Pati · NA · not yet recruiting
- NCT07520773 — Therapeutic Touch on Sleep, Comfort, and Physiological Parameters in Intensive Care Patients · NA · not yet recruiting
- NCT07521995 — Impact of Exercise Training on Serum Glial Fibrillary Acidic Protein (GFAP), Brain Volumetry, and Functional Outcomes in · NA · not yet recruiting
- NCT07520812 — Impact of Exercise Training on Serum Neurofilament Light Chain (NfL), Brain Volumetry, and Functional Outcomes in Multip · NA · not yet recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05341895 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Firat University
- Last refreshed: 22 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05341895.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing